Currently predicting for Wed, 3 Jul 2024

Trading levels for KPRX

Fibonacci Support & Resistance Levels

Level Price
R3 4.68 5.41%
R2 4.58 3.13%
R1 4.52 1.72%
Price 4.44
S1 4.31 -2.84%
S2 4.25 -4.25%
S3 4.15 -6.53%

Accumulated Volume Support & Resistance Levels

Level Price
R3 5.36 20.72%
R2 4.92 10.81%
R1 4.84 9.01%
Price 4.44
S1 4.35 -2.03%
S2 4.23 -4.73%
S3 4.00 -9.91%

KPRX Predictions History

5 months ago
SD1984 predicted that KPRX for Feb. 1st is going $1.12 (31.76%)

Rank:

10 months ago
JS predicted that KPRX for 2023-08-24 is going $0.688 (32.31%)

10 months ago
PredictionBot.Kathy predicted that KPRX for 2023-08-24 is going $0.609 (17.15%)

10 months ago
PredictionBot.Warren predicted that KPRX for 2023-08-24 is going $0.615 (18.29%)

10 months ago
PredictionBot.Kathy predicted that KPRX for 2023-08-08 is going $0.585 (4.40%)

10 months ago
PredictionBot.Warren predicted that KPRX for 2023-08-08 is going $0.580 (3.38%)

1 year ago
JS predicted that KPRX for 2023-01-20 is going $3.56 (-3.52%)

1 year ago
JS predicted that KPRX for 2022-09-19 is going $0.250 (11.61%)

1 year ago
PredictionBot.Kathy predicted that KPRX for 2022-09-19 is going $0.228 (1.71%)

1 year ago
PredictionBot.Warren predicted that KPRX for 2022-09-19 is going $0.210 (-6.16%)

Click to get the best stock tips daily for free!

About Kiora Pharmaceuticals, Inc.

Kiora Pharmaceuticals. Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 1 clinical trial that acts as a photoswitch to restore vision in patients with inherited and age-related degenerative retinal diseases. The company is also developing KIO-101, a... KPRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT